Evidence for Cyclophosphamide-Induced Transitional Cell Carcinoma in a Renal Transplant Patient-Reference-Cited by-同舟云学术

Evidence for Cyclophosphamide-Induced Transitional Cell Carcinoma in a Renal Transplant Patient

Published:1988-11 Issue:5 Part 1 Volume:140 Page:1009-1011
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Tuttle Todd M.¹,Williams G. Melville¹,Marshall Fray F.¹

Affiliation:

1. From the James Buchanan Brady Urological Institute and the Division of Transplant and Vascular Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Clinical pharmacology and preliminary evaluation of Cytoxan (cyclophosphamide);Coggins;Cancer Chemother. Rep.,1959

2. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy;Johnson;New Engl. J. Med.,1971

3. Cyclophosphamide and the bladder;Worth;Brit. Med. J.,1971

4. Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature;Samra;Med. Ped. Oncol.,1985

5. Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis;Ansher;Arth. Rheum.,1983

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder Cancer in Renal Allograft Recipients: Risk Factors and Outcomes;Transplantation Proceedings;2014-12

2. Cystitis: From Urothelial Cell Biology to Clinical Applications;BioMed Research International;2014

3. Urological Complications After Kidney Transplantation;Kidney Transplantation–Principles and Practice;2014

4. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population;BJU International;2012-01-13

5. Management of Bladder Cancer following Solid Organ Transplantation;Advances in Urology;2011